Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.
The collaboration combines Celonic’s biologics expertise with Carbogen Amcis’s payload and conjugation capabilities to create a seamless, end-to-end ADC development pathway.
First commercially available cell culture solution for HEK293 cells and perfusion, optimized for high cell density, intensified processes and perfusion cultures.
Metabolic conditioning is emerging as a powerful strategy to enhance the potency, persistence, and manufacturability of next-generation cell therapies, providing new hope for hard to treat cancers.